Anti-Human Ganglioside GD2 Recombinant Antibody(Naxitamab)

Name: Anti-Human Ganglioside GD2 Recombinant Antibody(Naxitamab)
Brand: KMD Bioscience
SKU: YR1539

YR1539

科研级 Naxitamab (那昔妥单抗 ), Anti-Ganglioside GD2 Recombinant Antibody, Research Grade Naxitamab

DATASHEET MSDS

Product Description

Alias	科研级 Naxitamab (那昔妥单抗 ), Anti-Ganglioside GD2 Recombinant Antibody, Research Grade Naxitamab
Catalog Number	YR1539
Molecular Name	Naxitamab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Naxitamab, sold under the brand name Danyelza, is an anti-cancer medication. It is a monoclonal antibody used in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) for people one year of age and older with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow demonstrating a partial response, minor response, or stable disease to prior therapy.
CAS Number	1879925-92-4
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	Ganglioside GD2[Homo sapiens]

Login